参考文献/References:
[1] Zhang S,Wang Y,Cheng J,et al.Hyperuricemia and cardiovascular disease[J].Curr Pharm Des,2019,25(6):700-709.DOI:10.2174/1381612825666190408122557.
[2] Tai V,Merriman TR,Dalbeth N. Genetic advances in gout:potential applications in clinical practice[J].Curr Opin Rheumatol,2019,31(2):144-151.DOI:10.1097/BOR.0000000000000571.
[3] Tin A,Woodward OM,Kao WHL,et al. Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele[J].Hum Mol Genet,2011,20(20):4056-4068.DOI:10.1093/hmg/ddr307.
[4] Kolz M,Johnson T,Sanna S,et al. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations[J].PLoS Genetics,2009,5(6):e1000504.DOI:10.1371/journal.pgen.1000504.
[5] Matsuo H,Yamamoto K,Nakaoka H,et al. Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes[J].Ann Rheum Dis,2016,75(4):652-659.DOI:10.1136/annrheumdis-2014-206191.
[6] Nakayama A,Matsuo H,Nakaoka H,et al. Common dysfunctional variants of ABCG2 have stronger impact on hyperuricemia progression than typical environmental risk factors[J].Sci Rep,2014,4:5227.DOI:10.1038/srep05227.
[7] Ying Y,Chen Y,Zhang S,et al. Investigation of serum biomarkers in primary gout patients using iTRAQ-based screening[J].Clin Exp Rheumatol,2018,36(5):791-797.
[8] Novikov A,Fu Y,Huang W,et al. SGLT2 inhibition and renal urate excretion:role of luminal glucose,GLUT9,and URAT1[J].Am J Physiol Renal Physiol,2019,316(1):F173-F185.DOI:10.1152/ajprenal.00462.2018.
[9] Feng Y,Lin S,Zhao X,et al. Taurine inhibited uric acid uptake in HK-2 renal tubular epithelial cells[J].Adv Exp Med Biol,2019,1155:147-154.DOI:10.1007/978-981-13-8023-5_13.
[10] Hediger MA,Clémençon B,Burrier RE,et al.The ABCs of membrane transporters in health and disease(SLC series):introduction[J].Mol Aspects Med,2013,34(2-3):95-107.DOI:10.1016/j.mam.2012.12.009.
[11] Yong T,Chen S,Xie Y,et al. Hypouricemic effects of armillaria mellea on hyperuricemic mice regulated through OAT1 and CNT2[J].Am J Chin Med,2018,46(3):585-599.DOI:10.1142/S0192415X18500301.
[12] Wang K,Hu L,Chen JK. RIP3-deficience attenuates potassium oxonate-induced hyperuricemia and kidney injury[J].Biomed Pharmacother,2018,101:617-626.DOI:10.1016/j.biopha.2018.02.010.
[13] Engelhart DC,Granados JC,Shi D,et al. Systems biology analysis reveals eight SLC22 transporter subgroups,including OATs,OCTs,and OCTNs[J].Int J Mol Sci,2020,21(5):1791.DOI:10.3390/ijms21051791.
[14] Sakiyama M,Matsuo H,Shimizu S,et al. A common variant of organic anion transporter 4(OAT4/SLC22A11)gene is associated with renal underexcretion type gout[J].Drug Metab Pharmacokinet,2014,29(2):208-210.DOI:10.2133/dmpk.dmpk-13-nt-070.
[15] Tan PK,Liu S,Gunic E,et al.Discovery and characterization of verinurad,a potent and specific inhibitor of URAT1 for the treatment of hyperuricemia and gout[J].Sci Rep,2017,7(1):665.DOI:10.1038/s41598-017-00706-7.
[16] Sakiyama M,Matsuo H,Shimizu S,et al.The effects of URAT1/SLC22A12 nonfunctional variants,R90H and W258X,on serum uric acid levels and gout/hyperuricemia progression[J].Sci Rep,2016,6:20148.DOI:10.1038/srep20148.
[17] Martínez-Reyes CP,Manjarrez-Reyna AN,Méndez-García LA,et al. Uric acid has direct proinflammatory effects on human macrophages by increasing proinflammatory Mediators and bacterial phagocytosis probably via URAT1[J].Biomolecules,2020,10(4):576.DOI:10.3390/biom10040576.
[18] Matsuo H,Nakayama A,Sakiyama M,et al.ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload[J].Sci Rep,2014,4:3755.DOI:10.1038/srep03755.
[19] Matsuo H,Ichida K,Takada T,et al. Common dysfunctional variants in ABCG2 are a major cause of early-onset gout[J].Sci Rep,2013,3:2014.DOI:10.1038/srep02014.
[20] Ristic B,Sivaprakasam S,Narayanan M,et al. Hereditary hemochromatosis disrupts uric acid homeostasis and causes hyperuricemia via altered expression/activity of xanthine oxidase and ABCG2[J].Biochem J,2020,477(8):1499-1513.DOI:10.1042/BCJ20190873.
[21] Mandal AK,Mount DB. Interaction between ITM2B and GLUT9 links urate transport to neurodegenerative disorders[J].Front Physiol,2019,10:1323.DOI:10.3389/fphys.2019.01323.
[22] Pantouris G,Dioletis E,Chen Y,et al. Expression,purification and crystallization of the novel Xenopus tropicalis ALDH16B1,a homologue of human ALDH16A1[J].Chem Biol Interact,2019,304:168-172.DOI:10.1016/j.cbi.2019.03.009.
[23] Charkoftaki G,Chen Y,Han M,et al.Transcriptomic analysis and plasma metabolomics in Aldh16a1-null mice reveals a potential role of ALDH16A1 in renal function[J].Chem Biol Interact,2017,276:15-22.DOI:10.1016/j.cbi.2017.02.013
[24] Chen M,Lu X,Lu C,et al. Soluble uric acid increases PDZK1 and ABCG2 expression in human intestinal cell lines via the TLR4-NLRP3 inflammasome and PI3K/Akt signaling pathway[J].Arthritis Res Ther,2018,20(1):20.DOI:10.1186/s13075-018-1512-4
[25] Srivastava S,Nakagawa K,He X,et al. Identification of the multivalent PDZ protein PDZK1 as a binding partner of sodium-coupled monocarboxylate transporter SMCT1(SLC5A8)and SMCT2(SLC5A12)[J].J Physiol Sci,2019,69(2):399-408.DOI:10.1007/s12576-018-00658-1
[26] Kuo TM,Huang CM,Tu HP,et al.URAT1 inhibition by ALPK1 is associated with uric acid homeostasis[J].Rheumatology(Oxford),2017,56(4):654-659.DOI:10.1093/rheumatology/kew463.
相似文献/References:
[1]黄江燕,董力,邹贵勉,等.广西城市社区居民高尿酸血症流行病学调查[J].国际内分泌代谢杂志,2014,(01):5.[doi:10.3760/cma.j.issn.1673-4157.2014.01.002]
Huang Jiangyan*,Dong Li,Zou Guimian,et al.Epidemiological survey of hyperuricemia in the Guangxi urban community residents[J].International Journal of Endocrinology and Metabolism,2014,(03):5.[doi:10.3760/cma.j.issn.1673-4157.2014.01.002]
[2]王靖宇,常宝成.高尿酸血症/痛风流行病学特点及危险因素[J].国际内分泌代谢杂志,2016,36(02):78.[doi:10.3760/cma.j.issn.1673-4157.2016.02.002]
Wang Jingyu,Chang Baocheng..Epidemiological characteristics and risk factors of hyperuricemia/gout[J].International Journal of Endocrinology and Metabolism,2016,36(03):78.[doi:10.3760/cma.j.issn.1673-4157.2016.02.002]
[3]聂秀玲,李明珍,孙丽荣.高尿酸血症与非酒精性脂肪性肝病[J].国际内分泌代谢杂志,2016,36(02):89.[doi:10.3760/cma.j.issn.1673-4157.2016.02.004]
Nie Xiuling,Li Mingzhen,Sun Lirong..Hyperuricemia and non-alcoholic fatty liver[J].International Journal of Endocrinology and Metabolism,2016,36(03):89.[doi:10.3760/cma.j.issn.1673-4157.2016.02.004]
[4]李明珍,聂秀玲,孙丽荣.高尿酸血症与糖代谢异常的关系[J].国际内分泌代谢杂志,2016,36(04):217.[doi:10.3760/cma.j.issn.1673-4157.2016.04.01]
Li Mingzhen,Nie Xiuling,Sun Lirong.Relationship between hyperuricemia and abnormalities of glucose metabolism[J].International Journal of Endocrinology and Metabolism,2016,36(03):217.[doi:10.3760/cma.j.issn.1673-4157.2016.04.01]
[5]刘彤,杨亚娟.高尿酸血症与心房颤动的关系[J].国际内分泌代谢杂志,2016,36(04):220.[doi:10.3760/cma.j.issn.1673-4157.2016.04.02]
Liu Tong,Yang Yajuan.Relationship between hyperuricemia and atrial fibrillation[J].International Journal of Endocrinology and Metabolism,2016,36(03):220.[doi:10.3760/cma.j.issn.1673-4157.2016.04.02]
[6]刘华英,顾丹阳,邵加庆.高尿酸血症与内皮功能障碍[J].国际内分泌代谢杂志,2016,36(06):412.[doi:10.3760/cma.j.issn.1673-4157.2016.06.14]
Liu Huaying,Gu Danyang,Shao Jiaqing..Hyperuricemia and endothelial dysfunction[J].International Journal of Endocrinology and Metabolism,2016,36(03):412.[doi:10.3760/cma.j.issn.1673-4157.2016.06.14]
[7]曹雯,孙洪平,褚晓秋,等.生活方式干预与高尿酸血症[J].国际内分泌代谢杂志,2017,37(03):172.[doi:10.3760/cma.j.issn.1673-4157.2017.03.007]
Cao Wen,Sun Hongping,Chu Xiaoqiu,et al.Lifestyle intervention and hyperuricemia[J].International Journal of Endocrinology and Metabolism,2017,37(03):172.[doi:10.3760/cma.j.issn.1673-4157.2017.03.007]
[8]牛紫如,陆强.高尿酸血症与不良妊娠结局[J].国际内分泌代谢杂志,2022,42(02):142.[doi:10.3760/cma.j.cn121383-20201114-11029]
Niu Ziru,Lu Qiang..Hyperuricemia and adverse pregnancy outcomes[J].International Journal of Endocrinology and Metabolism,2022,42(03):142.[doi:10.3760/cma.j.cn121383-20201114-11029]
[9]吴丹,李竹.H型高血压患者血尿酸与左心室重构的关系[J].国际内分泌代谢杂志,2023,43(02):91.[doi:10.3760/cma.j.cn121383-20211129-11083]
Wu Dan,Li Zhu..Relationship between serum uric acid and left ventricular remodeling in patients with H-type hypertension[J].International Journal of Endocrinology and Metabolism,2023,43(03):91.[doi:10.3760/cma.j.cn121383-20211129-11083]